Status:

UNKNOWN

The Dose Range of Remimazolam Besylate in Different Age Groups

Lead Sponsor:

Tongji Hospital

Collaborating Sponsors:

Renmin Hospital of Wuhan University

Wuhan University

Conditions:

Remimazolam

Anesthesia

Eligibility:

All Genders

45+ years

Phase:

NA

Brief Summary

This is a multicenter, randomized, parallel, controlled clinical study of patients at different ages underwent elective non-cardiac surgery under general anesthesia. The aim of this study is to explor...

Detailed Description

Surgery is an effective method to treat surgical diseases, prolong survival time and improve the quality of life, but patients often face the risk of postoperative complications. In general surgery pa...

Eligibility Criteria

Inclusion

  • age above 45 years old;
  • American Society of Anesthesiologists grade Ⅰ-II;
  • patients undergoing tracheal intubation or laryngeal mask airway surgery under general anesthesia (intravenous anesthesia);
  • Informed consent: patients voluntarily participated in the trial and signed the informed consent form.

Exclusion

  • patients with cardiac function grade 3 or above;
  • difficult to observe the pupil size of head or neck surgery patients;
  • patients with multimodal anesthesia such as nerve block or spinal anesthesia compounded;
  • patients known to be allergic to remimazolam besylate or benzodiazepines;
  • major vascular surgery and the type of surgery that directly affects hemodynamics;
  • patients with coagulation dysfunction, endocrine diseases or other hemodynamic conditions;
  • minor surgery (operation duration \<1 hour);
  • surgery lasting more than 4 hours;
  • emergency surgery;
  • patients with a history of drug or alcohol dependence;
  • Subjects deemed unsuitable for the study by the investigator.

Key Trial Info

Start Date :

July 17 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

1876 Patients enrolled

Trial Details

Trial ID

NCT06009991

Start Date

July 17 2023

End Date

December 31 2025

Last Update

September 6 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

ongji Hospital, Tongji Medical College, Huazhong Science and Technology University

Wuhan, Hubei, China, 430030

The Dose Range of Remimazolam Besylate in Different Age Groups | DecenTrialz